ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR991/009/SRR9916519/SRR9916519_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/001/SRR9916511/SRR9916511_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/000/SRR9916510/SRR9916510_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/008/SRR9916498/SRR9916498_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/009/SRR9916499/SRR9916499_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/004/SRR9916514/SRR9916514_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/006/SRR9916516/SRR9916516_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/005/SRR9916505/SRR9916505_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/007/SRR9916517/SRR9916517_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/003/SRR9916513/SRR9916513_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/006/SRR9916506/SRR9916506_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/009/SRR9916519/SRR9916519_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/001/SRR9916511/SRR9916511_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/007/SRR9916507/SRR9916507_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/008/SRR9916518/SRR9916518_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/002/SRR9916512/SRR9916512_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/001/SRR9916521/SRR9916521_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/009/SRR9916509/SRR9916509_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/005/SRR9916505/SRR9916505_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/000/SRR9916520/SRR9916520_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/008/SRR9916508/SRR9916508_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/003/SRR9916503/SRR9916503_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/004/SRR9916504/SRR9916504_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/000/SRR9916510/SRR9916510_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/001/SRR9916501/SRR9916501_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/002/SRR9916502/SRR9916502_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/006/SRR9916506/SRR9916506_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/007/SRR9916507/SRR9916507_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/000/SRR9916500/SRR9916500_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/008/SRR9916508/SRR9916508_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/000/SRR9916520/SRR9916520_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/001/SRR9916521/SRR9916521_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/009/SRR9916509/SRR9916509_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/004/SRR9916504/SRR9916504_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/009/SRR9916499/SRR9916499_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/003/SRR9916503/SRR9916503_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/005/SRR9916515/SRR9916515_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/005/SRR9916515/SRR9916515_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/004/SRR9916514/SRR9916514_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/006/SRR9916516/SRR9916516_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/008/SRR9916498/SRR9916498_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/001/SRR9916501/SRR9916501_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/007/SRR9916517/SRR9916517_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/003/SRR9916513/SRR9916513_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/002/SRR9916502/SRR9916502_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/000/SRR9916500/SRR9916500_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/008/SRR9916518/SRR9916518_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR991/002/SRR9916512/SRR9916512_1.fastq.gzprimaryOK200GenomicsMolecular Pathology, IDIBAPShttps://www.ebi.ac.uk/ena/browser/view/PRJNA559087Homo sapiensRNAseq analysis of 12 human macrophage samples was performed using ribosomal-depleted total RNA to analyze long non-coding RNA and coding transcript expression profiles comparing macrophage in vitro subtypes (M2, M1 and TAM) obtained from peripheral blood normal monocytes. Overall design: Dataset included RNA-seq data (Four Fastq files per sample as paired end sequencing was performed and two replicates per sample were included to increase the total number of reads to 100M) from ribosomal-depleted total RNA of macrophage in vitro subtypes obtained from peripheral blood normal monocytes to analyze their long non-coding RNA and coding transcript expression profiles. Sample metadata is referred to the in vitro treatments performed on to the different monocyte samples to obtain the macrophage subtypes of interest: M2 using M-CSF (N=3), M1 using GM-CSF (N=6), TAM using conditioned media from the follicular lymphoma cell line WSU-FSCCL (N=3).ENACSF-M, Therapy, CSF2, M-CSF, human being, Lanimostim, Monocyte Derived Macrophages, Macrophages, MCSF, Processed macrophage colony-stimulating factor 1, Gm-csf, Gm-CSf, molgramostin, Colony-stimulating factor 1, MGI-IGM, Bone Marrow Derived Macrophages, Colony Stimulating Factor, GM-CSF, Bone Marrow-Derived Macrophage, Monocyte Derived, CSF, Csfgm, Colony-stimulating factor, man, Treatments, human, Colony Stimulating Factor 1, Bone Marrow-Derived, sargramostim., Monocyte-Derived, Molgramostin, Therapeutic, Sargramostim, Gmcsf, CSF-1, Bone Marrow-Derived Macrophages, Monocyte-Derived Macrophage, Therapies, colony-stimulating factor, Colony-Stimulating Factor, Treatment, Colony-Stimulating Factor 1, GMCSF, Monocyte-Derived Macrophages, MacrophageCSF-M, Therapy, CSF2, M-CSF, human being, Lanimostim, Monocyte Derived Macrophages, Macrophages, MCSF, Processed macrophage colony-stimulating factor 1, Gm-csf, Gm-CSf, molgramostin, Colony-stimulating factor 1, MGI-IGM, Bone Marrow Derived Macrophages, Colony Stimulating Factor, GM-CSF, Bone Marrow-Derived Macrophage, Monocyte Derived, CSF, Csfgm, Colony-stimulating factor, man, Treatments, human, Colony Stimulating Factor 1, Bone Marrow-Derived, sargramostim., Monocyte-Derived, Molgramostin, Therapeutic, Sargramostim, Gmcsf, CSF-1, Bone Marrow-Derived Macrophages, Monocyte-Derived Macrophage, Therapies, colony-stimulating factor, Colony-Stimulating Factor, Treatment, Colony-Stimulating Factor 1, GMCSF, Monocyte-Derived Macrophages, Macrophage0.00.00.00.00.0falseRNAseq of human macrophages obtained from in vitro treatments with M-CSF/GM-CSF/CM-WSU-FSCCLRNAseq of human macrophages obtained from in vitro treatments with M-CSF/GM-CSF/CM-WSU-FSCCL2022-06-252022-06-24PRJNA559087GSE1354919606